Renal Cancer Metastatic
6 clinical trials · Condition
◉ Watch Renal Cancer Metastatic
| Record | Firm | Date |
|---|---|---|
| Biomarkers of Angiogenesis for Response to Therapeutic Combination in Advanced or Metastatic Kidney Cancer (NCT05285579) | Assistance Publique - Hôpitaux de Paris | 2022-05-05 |
| CLARA: Somatic and Germline Mechanisms That Impact Renal Cancer Immunotherapy (NCT05215470) | Hospital das Clínicas de Ribeirão Preto | 2022-01-18 |
| SABR Combined with Axitinib and Toripalimab in Recurrent or Metastatic RCC (NCT06889649) | Peking University First Hospital | 2019-01-01 |
| BIOREN (Predictive BIOmarkers in Metastatic RENal Cancer) (NCT03628859) | Centre Leon Berard | 2018-12-21 |
| A Study of Anti-PD-1 Combinations of D-CIK Immunotherapy and Axitinib in Advanced Ranal Carcinoma (NCT03736330) | Sun Yat-sen University | 2018-09-08 |
| Nivolumab Plus Stereotactic Body Radiotherapy in II and III Line of Patients With Metastatic Renal Cell Carcinoma (NCT03469713) | Gruppo Oncologico Italiano di Ricerca Clinica | 2017-07-14 |
Track Renal Cancer Metastatic automatically
Every clearance here is in the API, with alerts when new ones post.